The obesity market still only has two clear leaders with approved GLP-1 medications, and frontrunners Eli Lilly and Novo ...

The Government has announced a pilot to test new ways to support patients living with obesity, in a bid to ease pressures on ...

New studies indicate that weight-loss drugs may lead to serious eye diseases and vision loss in some individuals, prompting ...

The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

New studies confirm a small increased risk of serious eye conditions and vision loss in people taking weight-loss drugs like Ozempic, Wegovy, and Mounjaro.

Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...

"Tirzepatide and other drugs like it, such as semaglutide, will help people living with obesity to lose weight, and as a ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...

Recent research suggests a possible increased risk of serious eye conditions, such as non-arteritic anterior ischaemic optic ...

"Pharmacotherapy can help people living with obesity improve overall health, not just lose weight," says Dr. Sue D. Pedersen, ...

Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Scholar Rock ...

Eli Lilly and Company (NYSE:LLY) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Eli Lilly and Company ...